Merrill Lynch Believes UnitedHealth (NYSE: UNH) Won’t Stop Here

Merrill Lynch analyst Kevin Fischbeck maintained a Buy rating on UnitedHealth (UNHResearch Report) today and set a price target of $400.00. The company’s shares closed last Tuesday at $342.66, close to its 52-week high of $367.95.

Fischbeck has an average return of 17.4% when recommending UnitedHealth.

According to TipRanks.com, Fischbeck is ranked #1124 out of 7119 analysts.

UnitedHealth has an analyst consensus of Strong Buy, with a price target consensus of $369.13.

See today’s analyst top recommended stocks >>

The company has a one-year high of $367.95 and a one-year low of $187.72. Currently, UnitedHealth has an average volume of 3.05M.

Based on the recent corporate insider activity of 128 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of UNH in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health services business serving the broad health care marketplace, including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the health care industry. The OptumRx segment provides pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minneapolis, MN.